“Although current evidence suggests switching completely from cigarette smoking to (vaping) reduces health risks, the ...

University of New Mexico researchers have received funding to launch an early-stage clinical trial of a vaccine engineered to ...

Prescient Therapeutics initiates first US site for the Phase 2a trial of PTX-100 in patients with relapsed/refractory ...

Aclaris Therapeutics Inc. (NASDAQ:ACRS) is one of the best low priced pharma stocks to buy now. On June 23, Aclaris ...

AtriCure (Nasdaq: ATRC) today announced the completion of enrollment in a study evaluating its AtriClip system for preventing ...

Presentation by trial principal investigator at the 2025 SNO/ASCO CNS Metastases Conference Plus will also host an ...

In this video interview, Ramita Tandon, chief biopharma officer at Walgreens, discusses the operational investments required ...

An expert discusses how emerging trial data, particularly from ASCENT-04, are reshaping first-line treatment strategies for PD-L1–positive metastatic triple-negative breast cancer (mTNBC) by ...

The THRIVE Phase 3 clinical trial in active TED evaluated 5 infusions of veligrotug or placebo administered every 3 weeks, ...

In many cases, we’ve simply layered new tools onto an outdated operating model. The structure beneath—the way clinical trials ...

Karen Peterson was diagnosed with stage 1 triple-negative breast cancer that quickly returned as stage 4. Joining a clinical ...

The goal with ProKidney Corp.'s rilparencel-branded therapy is "to demonstrate the therapy's potential to preserve kidney ...